|
NR on phase 1 Kidney Trial
|
1
|
Resverlogix Corp.
|
Jan 23, 2017 11:29AM
|
|
Re: NR on phase 1 Kidney Trial
|
2
|
Resverlogix Corp.
|
Jan 23, 2017 11:50AM
|
|
Re: Kerosene
|
1
|
Resverlogix Corp.
|
Jan 23, 2017 07:31PM
|
|
Re: It's Time For Zenith To Disclose
|
5
|
Zenith Epigenetics
|
Jan 31, 2017 10:03AM
|
|
Futility analysis
|
5
|
Resverlogix Corp.
|
Feb 08, 2017 10:23AM
|
|
Re: Zenith BIO CEO & Investor Conference 2017 Slides
|
3
|
Zenith Epigenetics
|
Feb 15, 2017 08:23AM
|
|
Re: Resverlogix BIO CEO & Investor Conference 2017 Slides
|
1
|
Resverlogix Corp.
|
Feb 15, 2017 12:48PM
|
|
Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
|
4
|
Zenith Epigenetics
|
Mar 03, 2017 10:01AM
|
|
Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
|
2
|
Zenith Epigenetics
|
Mar 03, 2017 11:04AM
|
|
Re: New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
|
3
|
Zenith Epigenetics
|
Mar 03, 2017 01:25PM
|
|
Re: At least we're getting some intersting trading...
|
4
|
Resverlogix Corp.
|
Mar 09, 2017 10:03AM
|
|
Re: "ONE of the KEY patents !"
|
2
|
Resverlogix Corp.
|
Mar 15, 2017 11:21AM
|
|
Re: Heavier than normal trading on the OTC for RVXCF
|
5
|
Resverlogix Corp.
|
Mar 16, 2017 03:54PM
|
|
Next week
|
6
|
Resverlogix Corp.
|
Mar 19, 2017 06:16PM
|
|
Re: Embargo
|
1
|
Zenith Epigenetics
|
Mar 31, 2017 11:27AM
|
|
Re: .... did you vote today...?... we're down a chunk...
|
3
|
Resverlogix Corp.
|
Apr 07, 2017 10:31AM
|
|
Re: Priceless on I.V. Regarding Zenith
|
6
|
Zenith Epigenetics
|
Apr 09, 2017 12:03PM
|
|
Re: One week til the EAS Congress in Prague....April 2017 Fact Sheet PDF
|
4
|
Resverlogix Corp.
|
Apr 15, 2017 01:03PM
|
|
Re: Month 10
|
6
|
Zenith Epigenetics
|
Apr 15, 2017 03:16PM
|
|
Re: This raises more questions than it answers...
|
2
|
Resverlogix Corp.
|
Apr 21, 2017 07:26PM
|
